Tesla stock rating reiterated at Buy by TD Cowen, citing product goals

TD Cowen reiterated its Buy rating on Tesla (TSLA) with a $374 price target, expressing increased confidence in the company's long-term trajectory after reviewing the CEO compensation proposal and its product milestones, which align with significant future EBITDA targets. This follows the unveiling of an ambitious new CEO compensation package for Elon Musk, potentially worth $1 trillion, contingent on achieving an $8.5 trillion market capitalization. Analyst sentiment is mixed, with some firms maintaining bullish ratings on the aggressive nature of these milestones, while others remain Neutral or Market Perform, reflecting diverse views on the achievability of such long-term growth and valuation targets and their implications for leadership stability.

Analysis

TD Cowen has reiterated its Buy rating on Tesla (TSLA) with a $374 price target, citing increased confidence in the company's long-term trajectory after a review of the CEO compensation proposal. The firm notes that the plan's product milestones align with its thesis and correspond to the first two EBITDA targets of $50 billion and $80 billion, which it estimates could be achieved around 2030. This detailed guidance is set against the backdrop of a separate, highly ambitious new compensation package for Elon Musk, potentially valued at $1 trillion, which is contingent on Tesla reaching an $8.5 trillion market capitalization. Analyst sentiment on these developments is divided; while TD Cowen, Cantor Fitzgerald (Overweight, $355), and Stifel (Buy, $440) view the aggressive milestones as a positive signal of long-term commitment and scalability, other firms like Baird (Neutral, $320) and William Blair (Market Perform) remain more cautious. The board's approval of updated indemnification agreements further underscores a strategic focus on leadership stability amidst these ambitious growth plans.

Key Decisions for Investors

• Investors with a bullish outlook can view the newly detailed product and EBITDA milestones as a more concrete long-term roadmap, reinforcing a buy-and-hold strategy if they share TD Cowen's confidence in the 2030 targets.
• Given the mixed analyst ratings and a valuation already considered high by some metrics, a cautious stance is warranted; one might consider the extreme ambition of an $8.5 trillion market cap target a significant risk factor.
• Monitor the company's progress towards the initial $50 billion and $80 billion EBITDA milestones, as achieving these will be a critical validation of the long-term strategic plan and its ambitious targets.
• The compensation and indemnification agreements reduce key-person risk by signaling long-term leadership commitment, a crucial factor for investors to consider when evaluating the company's governance and stability.